0000929638-24-000304.txt : 20240130
0000929638-24-000304.hdr.sgml : 20240130
20240130162310
ACCESSION NUMBER: 0000929638-24-000304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240126
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cormorant Asset Management, LP
CENTRAL INDEX KEY: 0001583977
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37348
FILM NUMBER: 24578491
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: 52ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-702-0388
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: 52ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: Cormorant Asset Management, LLC
DATE OF NAME CHANGE: 20130807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cormorant Global Healthcare Master Fund, LP
CENTRAL INDEX KEY: 0001618442
ORGANIZATION NAME:
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37348
FILM NUMBER: 24578490
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: 52ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-848-3429
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: 52ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Bihua
CENTRAL INDEX KEY: 0001599214
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37348
FILM NUMBER: 24578489
MAIL ADDRESS:
STREET 1: C/O CORMORANT ASSET MANAGEMENT, LP
STREET 2: 200 CLARENDON STREET, 52ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc.
CENTRAL INDEX KEY: 0001595097
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464348039
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 RIVER RIDGE DRIVE
CITY: NORWOOD
STATE: MA
ZIP: 02062
BUSINESS PHONE: 617-963-0103
MAIL ADDRESS:
STREET 1: 500 RIVER RIDGE DRIVE
CITY: NORWOOD
STATE: MA
ZIP: 02062
FORMER COMPANY:
FORMER CONFORMED NAME: SAV Acquisition Corp
DATE OF NAME CHANGE: 20131220
4
1
form4.xml
X0508
4
2024-01-26
0001595097
Corbus Pharmaceuticals Holdings, Inc.
CRBP
0001583977
Cormorant Asset Management, LP
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
02116
true
0001618442
Cormorant Global Healthcare Master Fund, LP
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
02116
true
0001599214
Chen Bihua
C/O CORMORANT ASSET MANAGEMENT, LP
200 CLARENDON STREET, 52ND FLOOR
BOSTON
MA
02116
true
false
Common Stock
2024-01-26
4
P
0
14388
25.73
A
456756
I
See Footnote
Common Stock
2024-01-26
4
P
0
15243
26.66
A
471999
I
See Footnote
Common Stock
2024-01-26
4
P
0
36747
27.7
A
508746
I
See Footnote
Common Stock
2024-01-26
4
P
0
31028
28.82
A
539774
I
See Footnote
Common Stock
2024-01-26
4
P
0
29244
29.42
A
569018
I
See Footnote
Common Stock
2024-01-26
4
P
0
2654
31
A
571672
I
See Footnote
Common Stock
2024-01-26
4
P
0
4125
31.86
A
575797
I
See Footnote
Common Stock
2024-01-26
4
P
0
3866
32.47
A
579663
I
See Footnote
Common Stock
2024-01-26
4
P
0
18055
33.71
A
597718
I
See Footnote
Common Stock
2024-01-26
4
P
0
31549
34.62
A
629267
I
See Footnote
Common Stock
2024-01-26
4
P
0
32295
35.83
A
661562
I
See Footnote
Common Stock
2024-01-26
4
P
0
16484
36.53
A
678046
I
See Footnote
Common Stock
2024-01-26
4
P
0
43754
37.49
A
721800
I
See Footnote
Common Stock
2024-01-26
4
P
0
3200
38.49
A
725000
I
See Footnote
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $25.12 to $26.11 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the "SEC"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below).
Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $26.14 to $27.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $27.13 to $28.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $28.12 to $29.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $29.13 to $30.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $30.99 to $31.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $31.29 to $32.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $32.14 to $33.01 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $33.18 to $34.02 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $34.17 to $35.10 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $35.15 to $36.11 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $36.15 to $37.02 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $37.22 to $37.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $38.25 to $38.98 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
2024-01-30
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP By: Cormorant Global Healthcare GP, LLC, its General Partner By: /s/ Bihua Chen, Managing Member
2024-01-30
/s/ Bihua Chen
2024-01-30